Skip to Content

Onconase Approval Status

FDA Approved: No
Brand name: Onconase
Generic name: ranpirnase
Company: Alfacell Corporation
Treatment for: Malignant Pleural Mesothelioma

Onconase (ranpirnase) is a ribonuclease enzyme in development for the treatment of unresectable malignant mesothelioma.

Development Status and FDA Approval Process for Onconase

DateArticle
Jan 28, 2009Alfacell Provides Onconase NDA Submission Update - Jan 28, 2009
Dec  8, 2008Alfacell Provides Onconase NDA Submission Update - Dec 8, 2008
Oct  2, 2006Alfacell Completes Non-Clinical Section of Rolling NDA for Lead Anticancer Drug Onconase

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide